Abstract
The FAM regimen for upper gastrointestinal cancer was developed during 1974. It incorporated three anticancer drugs which had demonstrated independent activity against gastric cancer: 5-fluorouracil, adriamycin [2], and mitomycin-C [3]. In an attempt to insure adequate patient tolerance and allow for chronic administration, an intermittent schedule was designed (Table 1). In particular, mitomycin-C was to be administered only once every 2 months because of its then appreciated delayed and cumulative bone marrow toxicity. We have recently reported the criteria for entry into this study, including the strict requirement for followable disease criteria for patient response, as well as the initial response rates and survival curves [1]. This progress report describes the updated results in the treatment of 62 patients with advanced and measurable gastric cancer.
This study was supported by NIH-NCI NOI-CM 67110. This work has been convected, in part, under the French-American Agreement in Cancer Research
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
MacDonald JS, Woolley PV, Smythe T, Ueno W, Hoth D, Schein PS (to be published) 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer
Moertel CG (1976) Chemotherapy of gastrointestinal cancer. Clin Gastroenterol 5:777
Moore GE, Bross IDJ, Ausman R, Nadler S, Jones R, Slack N, Rimm AA (1968) Efficacy of mitomycin-C in 346 patients with advanced cancer. Cancer Chemother Rep 52:641
Panettiere FJ, Heibrun L (1979) Experiences with two treatment schedules in the combination chemotherapy of advanced gastric carcinoma. In: Carter S, Crooke S (eds) Mitomycin-C: Current status and new developments. Academic Press, New York San Francisco London
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schein, P.S. et al. (1981). The FAM Regimen for Gastric Cancer: A Progress Report. In: Carter, S.K., Sakurai, Y., Umezawa, H. (eds) New Drugs in Cancer Chemotherapy. Recent Results in Cancer Research, vol 76. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81565-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-81565-2_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81567-6
Online ISBN: 978-3-642-81565-2
eBook Packages: Springer Book Archive